Piper Sandler Issues Positive Forecast for ALX Oncology (NASDAQ:ALXO) Stock Price
ALX Oncology (NASDAQ:ALXO – Free Report) had its target price raised by Piper Sandler from $8.00 to $9.00 in a report issued on Thursday morning,Benzinga reports. The brokerage currently has an overweight rating on the stock. A number of other analysts also recently weighed in on the stock. UBS Group reduced their price target on […]
